The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Reduction of interobserver variability (IOV) by FDG-PET–based tumor volume delineation (TVD) in radiotherapy planning for pancreatic cancer.
Jennifer Mary Rose Branagan
No relevant relationships to disclose
Charlotte Halle
No relevant relationships to disclose
Stephen Falk
No relevant relationships to disclose
Ganesh Radhakrishna
No relevant relationships to disclose
Rajarshi Roy
Other Remuneration - Roche; Sanofi
Thomas Crosby
No relevant relationships to disclose
Chris Hurt
No relevant relationships to disclose
Thomas B. Brunner
No relevant relationships to disclose
Somnath Mukherjee
Consultant or Advisory Role - Celgene